Skip to content

Effect of legume consumption on cardiovascular risk factors

Effect of legume consumption on serum adiponectin level, inflammatory biomarkers and cardiovascular risk factors in healthy first degree relatives of diabetic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201306212839N5
Enrollment
19
Registered
2013-07-01
Start date
2012-07-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

family history of diabetes. Family history of diabetes mellitus

Interventions

Intervention 1: intervention group: packs of legumes (60 grams), 4 time per week, for 6 week. Intervention 2: control group: healthy dietary recommendations, for 6 weeks.
Lifestyle
intervention group: packs of legumes (60 grams), 4 time per week, for 6 week
control group: healthy dietary recommendations, for 6 weeks

Sponsors

Isfahan university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age more than 30 years, lack of pregnancy and lactation, no history of liver and kidney diseases, cancers, allergies, hypo- and hyperthyroidism, gastrointestinal problems (bloating and irritable bowel syndrome) and psychosomatic problems. Not using of anti-inflammatory drugs (corticosteroids) and blood glucose lowering drugs (Metformin and Insulin). Not changes in body weight more than 3 kilograms during last two months. Not cigarette smoking. Not following a particular diet. Exclusion criteria: Not using recommended amounts of legumes, not following the research protocol, beginning to consume particular medications during the study, beginning to cigarette smoking during the study, being pregnant during the study, incidence of liver and kidney diseases, kidney stones, cancers, allergies, hypo- and hyperthyroidism, gastrointestinal problems (bloating and irritable bowel syndrome), trauma, surgery and psychosomatic problems during the study. To start Insulin use or blood glucose lowering drugs (Metformin) during the study, change in type and dosage of medications during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood pressure, weight, waist circumference, BMI, total cholesterol, HDL, LDL, TG, FBS, Hb A1C. Timepoint: at the begining of study and weeks 6, 8, 14. Method of measurement: manometer, scale, inelastic tape, biochemical tests.

Secondary

MeasureTime frame
IL-6, TNF, hs-CRP, adiponectin. Timepoint: at the begining of atudy and 6th, 8th and 14th week. Method of measurement: biochemical tests.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSahar Saraf-Bank

Isfahan university of medical sciences

saraf2shr@yahoo.com+98 31 1792 2776

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026